Table 1 Patient characteristics
Characteristics | N = 37 |
|---|---|
N/Sex | F = 25, M = 12 |
Age (years) | 43.9 ± 17.6 (24~79) |
PTMC before PLA | |
Maximum diameter (mm) | 5.1 ± 3.4 |
Volume (mm3) | 52.8 ± 30.6 |
Thyroid hormone levels before PLA | |
FT3 (pmol/L) | 4.1 ± 1.9 |
FT4 (ng/dL) | 1.6 ± 0.8 |
T3 (ng/dL) | 155 ± 37 |
T4 (μg/dL) | 8.6 ± 3.6 |
TSH (mU/L) | 2.6 ± 1.9 |
Volume of hydrodissection solution during PLA (mL) | 10.3 ± 9.7 (0~37) |
Total energy delivery during PLA (J) | 989.4 ± 417.6 (450~1750) |
Active time during PLA (s) | 165.9 ± 92.8 (150~500) |
Follow-up (months) | 16.5 ± 6.9 (12~24) |